BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17539595)

  • 1. Studies on aminoisonucleoside modified siRNAs: stability and silencing activity.
    Li ZS; Qiao RP; Du Q; Yang ZJ; Zhang LR; Zhang PZ; Liang ZC; Zhang LH
    Bioconjug Chem; 2007; 18(4):1017-24. PubMed ID: 17539595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
    Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
    FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference in mammalian cells by siRNAs modified with morpholino nucleoside analogues.
    Zhang N; Tan C; Cai P; Zhang P; Zhao Y; Jiang Y
    Bioorg Med Chem; 2009 Mar; 17(6):2441-6. PubMed ID: 19233658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
    Iwase R; Miyao H; Toyama T; Nishimori K
    Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of modification pattern-RNAi activity relationships by using siRNAs modified with 4'-thioribonucleosides.
    Hoshika S; Minakawa N; Shionoya A; Imada K; Ogawa N; Matsuda A
    Chembiochem; 2007 Nov; 8(17):2133-8. PubMed ID: 17924376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and properties of novel L-isonucleoside modified oligonucleotides and siRNAs.
    Zhang J; Chen Y; Huang Y; Jin HW; Qiao RP; Xing L; Zhang LR; Yang ZJ; Zhang LH
    Org Biomol Chem; 2012 Oct; 10(37):7566-77. PubMed ID: 22895883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Shibata A; Yoshikawa K; Wataya Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2008; (52):503-4. PubMed ID: 18776474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
    Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
    J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional comparison of single- and double-stranded siRNAs in mammalian cells.
    Xu Y; Linde A; Larsson O; Thormeyer D; Elmen J; Wahlestedt C; Liang Z
    Biochem Biophys Res Commun; 2004 Apr; 316(3):680-7. PubMed ID: 15033453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference induced by siRNAs modified with 4'-thioribonucleosides.
    Hoshika S; Minakawa N; Matsuda A
    Nucleic Acids Symp Ser (Oxf); 2005; (49):77-8. PubMed ID: 17150641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of conformational alteration induced by D-/L-isonucleoside incorporation in siRNA on their stability in serum and silencing activity.
    Huang Y; Chen Z; Chen Y; Zhang H; Zhang Y; Zhao Y; Yang Z; Zhang L
    Bioconjug Chem; 2013 Jun; 24(6):951-9. PubMed ID: 23682837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of bcr-abl mRNA by chemically modified siRNA.
    Murao S; Diala I; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):499-500. PubMed ID: 18776472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protocol for designing siRNAs with high functionality and specificity.
    Birmingham A; Anderson E; Sullivan K; Reynolds A; Boese Q; Leake D; Karpilow J; Khvorova A
    Nat Protoc; 2007; 2(9):2068-78. PubMed ID: 17853862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platination of the siRNA sense-strand modulates both efficacy and selectivity in vitro.
    Hägerlöf M; Hedman H; Elmroth SK
    Biochem Biophys Res Commun; 2007 Sep; 361(1):14-9. PubMed ID: 17632077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of nuclease-resistant siRNAs possessing universal overhangs.
    Ueno Y; Watanabe Y; Shibata A; Yoshikawa K; Takano T; Kohara M; Kitade Y
    Bioorg Med Chem; 2009 Mar; 17(5):1974-81. PubMed ID: 19200743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities.
    Ichihara M; Murakumo Y; Masuda A; Matsuura T; Asai N; Jijiwa M; Ishida M; Shinmi J; Yatsuya H; Qiao S; Takahashi M; Ohno K
    Nucleic Acids Res; 2007; 35(18):e123. PubMed ID: 17884914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing and utilization of siRNAs targeting RNA binding proteins.
    Kim DH; Behlke M; Rossi JJ
    Methods Mol Biol; 2008; 488():367-81. PubMed ID: 18982303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Naito T; Shibata A; Yoshikawa K; Kim HS; Wataya Y; Kitade Y
    Bioorg Med Chem; 2008 Aug; 16(16):7698-704. PubMed ID: 18644731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of siRNAs that contain internal variable-length spacer linkages.
    Efthymiou TC; Peel B; Huynh V; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5590-4. PubMed ID: 22850216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.